Variables Associated With Human Papillomavirus (HPV) Vaccine Acceptance by Men

Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance for men. Methods: A convenience sample of men aged 18 to 45 years read a one-page information sheet about HPV and the HPV vaccine, then completed a 29-item questionnaire. χ2 tests were used to determine whether differences in demographic, sexual, and vaccine-related variables existed between levels of wanting the HPV vaccine. Results: Positive correlates of HPV vaccine acceptance included higher education (P < .0001); hispanic ethnicity (P = .0003); wearing a seat belt most of the time (P = .02); regular tobacco use (P = <.001); not being sexually active (P = .0008); history of more than 10 female sexual partners (P = .0004); not having oral sex (P = .045); extreme worry about vaccine side effects (P < .0001); extreme concern about vaccine safety (P < .0001); the importance of getting vaccines (P < .0001); familiarity with HPV (P < .0001); and extreme importance of receiving the HPV vaccine (P < .0001). Conclusions: Men with greater general education, high-risk behaviors, and knowledge about HPV are more likely to want the HPV vaccine. Focused educational efforts should facilitate even wider acceptance of the HPV vaccine by men.

[1]  D. Ferris,et al.  HPV Vaccine Acceptance Among Mid-Adult Women , 2008, The Journal of the American Board of Family Medicine.

[2]  P. Ravaud,et al.  Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors , 2007, AIDS.

[3]  D. Ferris,et al.  Midadult Women's Attitudes About Receiving the Prophylactic Human Papillomavirus Vaccine , 2007, Journal of lower genital tract disease.

[4]  K. Ault.  Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials , 2007, The Lancet.

[5]  A. Giuliano,et al.  Human Papillomavirus Prevalence and Type Distribution in Male Anogenital Sites and Semen , 2007, Cancer Epidemiology Biomarkers & Prevention.

[6]  Daron G Ferris,et al.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. , 2007, The New England journal of medicine.

[7]  F. X. Bosch,et al.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions , 2007 .

[8]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[9]  A. Giuliano,et al.  Prevalence of HPV infection among men: A systematic review of the literature. , 2006, The Journal of infectious diseases.

[10]  Elizabeth M. Maloney,et al.  Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. , 2006, Archives of otolaryngology--head & neck surgery.

[11]  D. Ferris,et al.  Smokers at Higher Risk for Undetected Antibody for Oncogenic Human Papillomavirus Type 16 Infection , 2006, Cancer Epidemiology Biomarkers & Prevention.

[12]  C. Wheeler,et al.  Smoking Is a Risk Factor for Cervical Intraepithelial Neoplasia Grade 3 among Oncogenic Human Papillomavirus DNA–Positive Women with Equivocal or Mildly Abnormal Cytology , 2005, Cancer Epidemiology Biomarkers & Prevention.

[13]  Cosette M Wheeler,et al.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. , 2005, The Lancet. Oncology.

[14]  S. Syrjänen.  Human papillomavirus (HPV) in head and neck cancer. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[15]  T. R. Broker,et al.  Recurrent Respiratory Papillomatosis: A Longitudinal Study Comparing Severity Associated With Human Papilloma Viral Types 6 and 11 and Other Risk Factors in a Large Pediatric Population , 2004, The Laryngoscope.

[16]  F. Telischi,et al.  Vestibular Effects of Cochlear Implantation , 2004, The Laryngoscope.

[17]  D. Ferris,et al.  Human Papillomavirus Vaccine Acceptability Among Parents of 10- to 15-Year-Old Adolescents , 2004, Journal of lower genital tract disease.

[18]  J. Palefsky,et al.  High incidence of anal high‐grade squamous intra‐epithelial lesions among HIV‐positive and HIV‐negative homosexual and bisexual men , 1998, AIDS.

[19]  H. Adami,et al.  [Sexually transmitted infection as a cause of anal cancer]. , 1997, Ugeskrift for laeger.

[20]  D. Ferris,et al.  'See and treat' electrosurgical loop excision of the cervical transformation zone. , 1996, The Journal of family practice.

[21]  G. Haas,et al.  Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. , 1995, Journal of the National Cancer Institute.

[22]  M. Espy,et al.  Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of penis. , 1993, Urology.

[23]  B. Thiers.  Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions , 2008 .

[24]  M. Espy,et al.  The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. , 1995, The Journal of urology.